DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma.

One hundred and fifty patients with breast carcinoma were examined to compare axillary node status, estrogen receptor level and cellular DNA content as prognostic indicators. Seventy-four per cent of the patients were postmenopausal and forty per cent had axillary node metastases. Estrogen receptor was measured by isoelectric focusing in polyacrylamide gel. DNA was measured in individual cell nuclei by means of Feulgen-acriflavine-sulphate stained imprints. Fifty-two per cent of the tumors had diploid and/or tetraploid DNA pattern, and the rest aneuploid pattern. Axillary node metastases, aneuploid DNA pattern and low level of estrogen receptor were related to recurrence. When introduced into Cox's proportional hazards procedure, axillary nodes and estrogen receptor level but not DNA pattern remained as significant predictors of recurrence.

[1]  K. Bjelkenkrantz.  An evaluation of Feulgen-acriflavine-SO2 and Hoechst 33258 for DNA cytofluorometry in tumour pathology , 2004, Histochemistry.

[2]  P. Bichel,et al.  Estrogen receptor content and ploidy of human mammary carcinoma , 1982, Cancer.

[3]  B. Barlogie,et al.  Ploidy, proliferative activity and estrogen receptor content in human breast cancer. , 1982, Cytometry.

[4]  M. Melamed,et al.  Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor , 1981, Cancer.

[5]  B. Ljung,et al.  Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas. , 1980, Analytical and quantitative cytology.

[6]  H. Westerberg,et al.  Estrogen receptor level and other factors in early recurrence of breast cancer , 1980, International journal of cancer.

[7]  T. Caspersson,et al.  DNA content and survival in mammary carcinoma. , 1980, Analytical and quantitative cytology.

[8]  R. Kay,et al.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. , 1979, British Journal of Cancer.

[9]  J. Gustafsson,et al.  Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. , 1978, Analytical biochemistry.

[10]  E. J. Gregory,et al.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. , 1977, Cancer research.

[11]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[12]  W. Sandritter,et al.  DNA in human tumors: a cytophotometric study. , 1975, Current topics in pathology. Ergebnisse der Pathologie.

[13]  N. Breslow.  Covariance analysis of censored survival data. , 1974, Biometrics.

[14]  N. B. Atkin.  Modal Deoxyribonucleic Acid Value and Survival in Carcinoma of the Breast , 1972, British medical journal.

[15]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[16]  B. Fisher,et al.  Number of lymph nodes examined and the prognosis of breast carcinoma. , 1970, Surgery, gynecology & obstetrics.

[17]  K. A. Hultborn,et al.  Mammary carcionma. The biologic character of mammary carcionma studied in 517 cases by a new form of malignancy grading. , 1960, Acta radiologica. Supplementum.

[18]  M. Black,et al.  Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. , 1955, Surgery, gynecology & obstetrics.

[19]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[20]  H. Bloom.  Prognosis in Carcinoma of the Breast , 1950, British Journal of Cancer.